Streptococcal toxic shock syndrome is frequently caused by Streptococcus pyogenes of the M1 serotype. The aim of this study was to determine the role of Ras-homologous (Rho)-kinase signaling in M1 protein-provoked lung damage. Male C57BL/6 mice received the Rho-kinase-specific inhibitor Y-27632 before administration of M1 protein. Edema, neutrophil accumulation and CXC chemokines were quantified in the lung 4 h after M1 protein challenge. Flow cytometry was used to determine Mac-1 expression. Quantitative RT-PCR was used to determine gene expression of CXC chemokine mRNA in alveolar macrophages. M1 protein increased neutrophil accumulation, edema and CXC chemokine formation in the lung as well as enhanced Mac-1 expression on neutrophils. Inhibition of Rho-kinase signaling significantly reduced M1 protein-provoked neutrophil accumulation and edema formation in the lung. M1 protein-triggered pulmonary production of CXC chemokine and gene expression of CXC chemokines in alveolar macrophages was decreased by Y-27632. Moreover, Rho-kinase inhibition attenuated M1 protein-induced Mac-1 expression on neutrophils. We conclude that Rho-kinase-dependent neutrophil infiltration controls pulmonary tissue damage in response to streptococcal M1 protein and that Rho-kinase signaling regulates M1 protein-induced lung recruitment of neutrophils via the formation of CXC chemokines and Mac-1 expression.

Keywords:
Chemokines, Lung, Sepsis, Kinases, Leukocytes
1.
Cervera C, Almela M, Martinez-Martinez JA, Moreno A, Miro JM: Risk factors and management of Gram-positive bacteraemia. Int J Antimicrob Agents 2009;34(suppl 4):S26–S30.
2.
DiPiro JT: Pathophysiology and treatment of gram-negative sepsis. Am J Hosp Pharm 1990;47(11 suppl 3):S6–S10.
3.
Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–1554.
4.
Cunningham MW: Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000;13:470–511.
5.
Collin M, Olsen A: Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 2000;36:1306–1318.
6.
Pahlman LI, Malmstrom E, Morgelin M, Herwald H: M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology 2007;153:2458–2464.
7.
Pahlman LI, Morgelin M, Eckert J, Johansson L, Russell W, Riesbeck K, et al: Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 2006;177:1221–1228.
8.
Asaduzzaman M, Zhang S, Lavasani S, Wang Y, Thorlacius H: LFA-1 and MAC-1 mediate pulmonary recruitment of neutrophils and tissue damage in abdominal sepsis. Shock 2008;30:254–259.
9.
Tilanus AM, de Geus HR, Rijnders BJ, Dwarkasing RS, van der Hoven B, Bakker J: Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature. Int J Infect Dis 2010;14(suppl 3):e208–e212.
10.
Vuilleumier H, Halkic N: Streptococcal toxic shock syndrome revealed by a peritonitis. Case report and review of the literature. Swiss Surg 2001;7:25–27.
11.
Bacon KB, Oppenheim JJ: Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev 1998;9:167–173.
12.
Li X, Klintman D, Liu Q, Sato T, Jeppsson B, Thorlacius H: Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol 2004;75:443–452.
13.
Schramm R, Schaefer T, Menger MD, Thorlacius H: Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukoc Biol 2002;72:1122–1132.
14.
Zhang S, Zhang S, Rahman M, Herwald H, Thorlacius H: Streptococcal M1 protein-induced lung injury is independent of platelets in mice. Shock 2010;35:86–91.
15.
Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, et al: Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol 2002;72:571–579.
16.
Barton GM: A calculated response: control of inflammation by the innate immune system. J Clin Invest 2008;118:413–420.
17.
Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S: An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999;5:221–225.
18.
Slotta JE, Braun OO, Menger MD, Thorlacius H: Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo. Inflamm Res 2006;55:364–367.
19.
Niggli V: Rho-kinase in human neutrophils: a role in signalling for myosin light chain phosphorylation and cell migration. FEBS Lett 1999;445:69–72.
20.
Slotta JE, Laschke MW, Menger MD, Thorlacius H: Rho-kinase signalling mediates endotoxin hypersensitivity after partial hepatectomy. Br J Surg 2008;95:976–984.
21.
Kitamura K, Tada S, Nakamoto N, Toda K, Horikawa H, Kurita S, et al: Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. J Gastroenterol Hepatol 2007;22:2022–2033.
22.
Laschke MW, Dold S, Jeppsson B, Schilling MK, Menger MD, Thorlacius H: Rho-kinase inhibitor attenuates cholestasis-induced CXC chemokine formation, leukocyte recruitment, and hepatocellular damage in the liver. J Surg Res 2010;159:666–673.
23.
Santen S, Wang Y, Laschke MW, Menger MD, Jeppsson B, Thorlacius H: Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia-reperfusion. Int J Colorectal Dis 2010;25:1063–1070.
24.
Oka M, Fagan KA, Jones PL, McMurtry IF: Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension. Br J Pharmacol 2008;155:444–454.
25.
Awla D, Hartman H, Abdulla A, Zhang S, Rahman M, Regner S, et al: Rho-kinase signalling regulates trypsinogen activation and tissue damage in severe acute pancreatitis. Br J Pharmacol 2011;162:648–658.
26.
Kumar S, Boehm J, Lee JC: p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003;2:717–726.
27.
Kuldo JM, Ogawara KI, Werner N, Asgeirsdottir SA, Kamps JA, Kok RJ, et al: Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol 2005;3:11–39.
28.
Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, et al: Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem 2002;277:14884–14893.
29.
Zhang S, Rahman M, Zhang S, Wang Y, Herwald H, Jeppsson B, et al: p38 Mitogen-activated protein kinase signaling regulates streptococcal M1 protein-induced neutrophil activation and lung injury. J Leukoc Biol, 2012;91:137–145.
30.
Asaduzzaman M, Rahman M, Jeppsson B, Thorlacius H: P-selectin glycoprotein-ligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis. Br J Pharmacol 2009;156:307–315.
31.
Borzone G, Liberona L, Olmos P, Saez C, Meneses M, Reyes T, et al: Rat and hamster species differences in susceptibility to elastase-induced pulmonary emphysema relate to differences in elastase inhibitory capacity. Am J Physiol Regul Integr Comp Physiol 2007;293:R1342–R1349.
32.
Zhang X, Goncalves R, Mosser DM: The isolation and characterization of murine macrophages. Curr Protoc Immunol 2008; chapt 14:unit 14.1.
33.
Zhang S, Rahman M, Zhang S, Qi Z, Herwald H, Thorlacius H: Simvastatin regulates CXC chemokine formation in streptococcal M1 protein-induced neutrophil infiltration in the lung. Am J Physiol Lung Cell Mol Physiol 2011;300:L930–L939.
34.
Pahlman LI, Olin AI, Darenberg J, Morgelin M, Kotb M, Herwald H, et al: Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 2008;10:404–414.
35.
Ropert C, Closel M, Chaves AC, Gazzinelli RT: Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages. J Immunol 2003;171:1456–1465.
36.
Gao X, Xu N, Sekosan M, Mehta D, Ma SY, Rahman A, et al: Differential role of CD18 integrins in mediating lung neutrophil sequestration and increased microvascular permeability induced by Escherichia coli in mice. J Immunol 2001;167:2895–2901.
37.
Kamochi M, Kamochi F, Kim YB, Sawh S, Sanders JM, Sarembock I, et al: P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am J Physiol 1999;277:L310–L319.
38.
Herwald H, Cramer H, Morgelin M, Russell W, Sollenberg U, Norrby-Teglund A, et al: M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004;116:367–379.
39.
Menezes GB, Lee WY, Zhou H, Waterhouse CC, Cara DC, Kubes P: Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. J Immunol 2009;183:7557–7568.
40.
Zhang XW, Liu Q, Wang Y, Thorlacius H: CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol 2001;133:413–421.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.